EDAP TMS SA ADR (FOCL)

NASD · Healthcare · Medical Distribution · France

EDAP TMS SA ADR is a micro cap company (market value under $300 million) in the Medical Distribution industry.

EDAP TMS is a medical technology company that develops, manufactures, and markets non-invasive therapeutic ultrasound devices. The company offers its Focal One Robotic HIFU system for prostate cancer treatment in urology, along with legacy product lines and third-party distributions. EDAP operates globally and generates revenue from equipment sales, consumables, and maintenance services.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the EDAP TMS SA ADR stock.

Our verdict on FOCL

Not valued: We cannot value this company yet.

We do not publish a value for this company: not even its current assets cover what it owes.

Browse

• Stocks in France

Peers in Medical Distribution

• Mckesson Corp (MCK)
• Cencora Inc (COR)
• Cardinal Health Inc (CAH)
• Henry Schein Inc (HSIC)
• Akso Health Group ADR (AHG)
• Cosmos Health Inc (COSM)
• Accendra Health Inc (ACH)
• 111 Inc ADR (YI)

All 11 Medical Distribution stocks

Cheaper than FOCL in Medical Distribution

• Mckesson Corp (MCK): fairly valued, 0% margin of safety
• Henry Schein Inc (HSIC): slightly overvalued, -8% margin of safety
• Cencora Inc (COR): overvalued, -27% margin of safety
• Cardinal Health Inc (CAH): overvalued, -34% margin of safety

Is FOCL undervalued or overvalued?

We do not publish a verdict on FOCL yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of FOCL?

We do not publish one (as of the 2026-10-30 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.